LXRX
Companies
NASDAQ
Lexicon Pharmaceuticals, Inc.
Health Care
$0.74
+$0.00 (+0.54%)
Price Chart
Overview
About LXRX
Lexicon Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in the discovery, development, and commercialization of pharmaceutical products for the treatment of human diseases. Some of its drug candidates are LX9211, an orally-delivered small molecule drug candidate, as a treatment for neuropathic pain; and sotagliflozin, an orally-delivered small molecule drug candidate, as a treatment for heart failure and type 1 diabetes.
Market Cap
$632.6M
Volume
3.0M
Avg. Volume
4.4M
P/E Ratio
-0.9499999
Dividend Yield
0.00%
Employees
294.0
Company Information
Risk & Correlation Analysis
Market Correlation
1.82
High Correlation
Volatility
High (1.00)
Relative to market
Macro Factor Sensitivities
Interest Rates
Low Sensitivity
Inflation
High Sensitivity
GDP Growth
High Sensitivity
Liquidity
High Sensitivity
Commodity Prices
High Sensitivity
Credit Quality
High Sensitivity
Portfolio Impact
Forecasts & Predictions
1-Month Target
$XXX.XX
+X.X% Potential
3-Month Target
$XXX.XX
+X.X% Potential
12-Month Target
$XXX.XX
+X.X% Potential
Technical Analysis
Based on technical indicators and chart patterns, LXRX shows...
AI Sentiment Analysis
Market sentiment analysis indicates...
Key Statistics
Market Cap$632.6M
Volume3.0M
P/E Ratio-0.95
Dividend Yield0.00%
Important Dates
Next Dividend
Next Earnings
July 30, 2025Related Securities
Pricing info last updated June 18, 2025 (after market close)Other info last updated April 2, 2025